RxDoctor Payments DataLook up a doctor →

Alon Antebi, DO

Orthopaedic Trauma · Lancaster, CANPI 1639174816

Payments from drug & device makers

$745,251in general payments, 2019–2025

Across 132 payments — averaging $5645.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$602K
  • Arthrex$47K
  • Advanced Orthopaedic Solutions, Inc.$41K
  • US Implant Solutions, LLC$18K
  • Mimedx Group, Inc.$14K
  • Maxx Health Inc$9K
  • plus $13K from 23 others
$1,569in research payments, 2019–2025

Across 3 payments — averaging $523.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$745,251 in reported general payments places this provider in the 95th percentile of 106 orthopaedic trauma providers in California.

See all orthopaedic trauma providers in California

Medicare billing

Part B allowed, 2024
$399,098
Medicare patients
552
Services billed
3,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic trauma in Lancaster

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →